Rua Bioscience Expands International Reach to Canada.

Wednesday 7th February 2024

Tairawhiti, New Zealand – Rua Bioscience, a leading innovator in medicinal cannabis cultivation, is pleased to announce a ground-breaking agreement with Canada’s Apollo Green. This agreement marks a significant milestone in Rua Bioscience's strategy for growth by introducing its unique East Coast Tairawhiti cannabis strains to the Canadian market ultimately creating another pathway for revenue.

Apollo Green, a world leader in cannabis genetics, will now include Rua Bioscience's distinctive strains in its genetic library, that includes over 1000 unique cultivars. This collaboration is a testament to the global demand for diverse and high-quality cannabis genetics.

A wholly owned subsidiary of Biortica Agrimed, Apollo Green, has existing sales channels into Europe, North America and Australasia. It is a market leader in genetic distribution and licensing. Apollo Green provides access to breeder’s right protection through DNA fingerprinting of all genetics, access to cultivation capabilities world-wide and licensing opportunities delivering increased revenue opportunities to Rua Bioscience.

Biortica Agrimed is a leader in B2B medicinal cannabis cultivation and is one of Australia’s largest and fastest growing producer of medicinal cannabis.

“We welcome Rua to the Apollo Green and the Biortica Agrimed family” said Tom Varga, CEO of Biortica Agrimed.

The collaboration with Apollo Green enables the cultivation of Rua Bioscience's East Coast Tairawhiti strains in Canada, broadening the horizons for both companies in the global cannabis market.

“This agreement not only highlights Rua Bioscience's commitment to innovation and quality but also underscores the potential of New Zealand’s cannabis industry on the world stage.”

"We are excited about this partnership with Apollo Green and Biortica Agrimed, as it aligns perfectly with our vision to take our unique strains to the world," said Paul Naske, CEO of Rua Bioscience. "This is more than just an agreement; it's a bridge connecting New Zealand's exceptional cannabis genetics to the world."

ENDS

The person who authorised this announcement:

Paul Naske,

Chief Executive Officer

For shareholder enquiries please visit www.ruabio.com or contact:

info@ruabio.com

0800 RUABIO

ABOUT RUA BIOSCIENCE

As one of few Māori-born biotech businesses in Aotearoa, Rua Bioscience is the only New Zealand-based medicinal cannabis company with an explicit focus on delivering social impact. Licensed to cultivate since 2016, Rua, was the first company founded by a Māori community to list on the New Zealand stock exchange. Launching its first prescription medicine in April 2022. It’s strong social conscience is evidenced by its introduction of one of New Zealand’s first Compassionate Access schemes for medicinal cannabis.

www.ruabio.com

CONTACT: Paul Naske CEO, Rua Bioscience

paul.naske@ruabio.com

+64 21 445 154

ABOUT APOLLO GREEN

Licensed since July 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics

www.apollogreen.com

ABOUT BIORTICA

Biortica Agrimed Ltd is Australia’s largest fully vertically integrated commercial grower of medicinal plants. Our B2B operations are seamlessly integrated from plant genetics through to supply of medicinal plants in commercial quantities. We employ glasshouse-based horticulture, to both, protect our valuable medicinal crops, and equally to minimise our environmental impact, thereby protecting the planet. Our goal is to significantly improve human health outcomes by supplying high quality agricultural medicinal plants, at scale, to uniform high quality standards year-round, year-on-year.

Rua Bioscience Expands International Reach to Canada.

Comments from our readers

No comments yet